Prescription Drug Monitoring Program: Registration and Use by Prescribers and Pharmacists Before and After Legal Mandatory Registration, California

• NCJ Number: 253828
• Journal: American Journal of Public Health Volume: 108 Issue: 12 Dated: 2019 Pages: 1668-1674
• Author(s): Aaron B. Shev; Garen J. Wintemute; Magdalena Cerda; Andrew Crawford; Susan L. Stewart; Stephen G. Henry
• Date Published: 2019
• Length: 6 pages
• Grant Number(s): 2015-PM-BX-K001
• Sponsoring Agency: Bureau of Justice Assistance (BJA)
• Publication Format: Article
• Publication Type: Research (Applied/Empirical); Report (Study/Research); Report (Grant Sponsored); Program/Project Description; Legislation/Policy Description
• Language: English
• Country: United States of America

Annotation

This study estimated the effect of California's prescription drug monitoring program's (PDMP) registration mandate on use of the PDMP.

Abstract

The effect of Californias mandatory PDMP registration law was evaluated by fitting time series models on the percentage of clinicians registered for Californias PDMP and the percentage of clinicians who were active PDMP users (users who created greater than or equal to 1 patient prescription reports in a given month) from 2010 through 2017. The study also compared PDMP use among early PDMP adopters (clinicians who registered greater than or equal to 8 months before the mandatory registration deadline) compared with late adopters (clinicians who registered less than or equal to 8 months before the deadline). The findings indicate that mandatory registration was associated with increases in active PDMP users; i.e., a 53.5-percent increase for prescribers and a 17.9-percent increase for pharmacists. Early adopters were four times more likely to be active PDMP users than were late adopters. The study concludes that mandatory PDMP registration increases PDMP use but does not result in widespread PDMP use by all clinicians who prescribe controlled substances. (publisher abstract modified)